#BioPharma
My blog has been running since 2002, but my secret is that it was never my source of income. Day job(s) in biopharma research the whole time I’ve been writing about biopharma research.
March 20, 2026 at 10:01 PM
I forgot to post this here:

Worst Biopharma CEO of 2024? It’s no contest www.statnews.com/2024/12/18/w... via @statnews.com
Worst Biopharma CEO of 2024? It's no contest
Remi Barbier, the former CEO of Cassava Sciences, was declared the Worst Biopharma CEO of 2024 by @adamfeuerstein.
www.statnews.com
December 19, 2024 at 12:10 AM
Call to arms by @lisamjarvis.bsky.social for biopharma to mobilize in support of the engines that power them - federally supported biomedical research and drug evaluation
Noticeably silent amid the upheaval at HHS? Big pharma. Every new drug has NIH somewhere in its DNA--and NIH funding supports the training of their workforce. Now they're finding out FDA isn't safe, either. Wrote about how keeping quiet isn't working My latest @opinion.bloomberg.com (gift link):
Big Pharma Needs to Get Off the Sidelines
The industry can’t continue to sit idly by while Robert F. Kennedy Jr. guts the nation’s public health agencies.
www.bloomberg.com
April 1, 2025 at 5:38 PM
Is it woke to point out that Vivek defrauded investors in his crappy biopharma company?
September 6, 2026 at 5:34 PM
Det våras för Hansa Biopharma!

Ny analys: drive.google.com/file/d/1ITil...

$HNSA
October 5, 2025 at 6:14 AM
given that this guy’s married to a psilocybin biopharma lobbyist, i have a suspicion that he’s been hanging around intellectual dork web dweebs and VC scumbags for awhile
April 11, 2024 at 8:44 PM
Remi Barbier, the former — and currently disgraced — CEO of Cassava Sciences, is the Worst Biopharma CEO of 2024.

@adamfeuerstein.bsky.social writes @statnews.bsky.social
He also included Barbier on 2021, 2022, 2023 Worst CEO lists and hopes this year is last time.

www.statnews.com/2024/12/18/w...
Worst Biopharma CEO of 2024? It's no contest
Remi Barbier, the former CEO of Cassava Sciences, was declared the Worst Biopharma CEO of 2024 by @adamfeuerstein.
www.statnews.com
December 18, 2024 at 6:07 PM
Biopharma companies and CEOs are keeping their heads down at their own peril. They should speak up about what’s happening to the NIH and other science agencies before it’s too late.

Silence gives consent. And no one should consent to this.
Stand Up And Be Counted
www.science.org
February 12, 2025 at 4:45 PM
It’s the tone that I only hit with anti-vaccine activists, HIV retroviral drug denialists, and quack cancer-cure vultures.

And now with biopharma CEOs. What a world.
Biomed research & Pharma blogger @dereklowe.bsky.social is noted for his measured tone - more 'journal editorial', less 'blog ranting'. But this blog on some big Pharma CEOs talking up 'opportunities' for working w the Trumpkins is as angry as I've ever seen him.
www.science.org/content/blog...
Pharma CEOS Speaking Up, Damn It
www.science.org
February 20, 2025 at 12:39 AM
85% of all human clinical drug trials fail. The central fact of the biopharma industry, right there.
ok i have another quote tweet prompt. what's something, big or small, related to your job or hobby, that most people don't know that you would like to have them know? it can be a concept, a piece of history, some vocabulary, or something else.
June 17, 2024 at 12:30 AM
Building a global biotech powerhouse in Canada 🍁

U.S. scientists fleeing the chaos & uncertainty, we welcome you 🧬

www.nature.com/articles/d43...
Building a global biotechnology powerhouse in Canada
Canadian biopharma companies are capitalizing on increased government investment stimulated by the recent pandemic to strengthen domestic capabilities and foster multinational partnerships that enhanc...
www.nature.com
February 8, 2025 at 12:48 AM
The single most important number the biopharma business: our failure rate.
Clinical Failure Rates Over the Decades: Yikes
www.science.org
July 27, 2026 at 4:54 PM
Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
cnb.cx
September 21, 2026 at 4:25 AM
NEW: Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.

More info ⬇️
Oxford and GSK launch £50million immuno-prevention programme to
Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent
www.ox.ac.uk
January 27, 2025 at 10:46 AM
Well said @dereklowe.bsky.social. Academia produces two vital products: (1) knowledge, and (2) human capital that knows how to use it. If we can’t train enough young creative US scientists to fulfill biopharma industry needs…

“I think they're being short-sighted, because fear does that to you.”
Biopharma companies and CEOs are keeping their heads down at their own peril. They should speak up about what’s happening to the NIH and other science agencies before it’s too late.

Silence gives consent. And no one should consent to this.
Stand Up And Be Counted
www.science.org
February 12, 2025 at 7:41 PM
good to keep an eye on possible conflicts of interest. will say - biopharma feels very distinct from health insurance in the context of this case.
December 24, 2024 at 4:33 AM
On the fraught relationship between foreign biopharma and Chinese contractors, and on the US Congressional efforts to get involved in it. Which aren't helping anyone.
The US and Chinese Biopharma Contractors
www.science.org
March 13, 2024 at 4:39 PM
2b. A healthy, well funded NIH is essential to maintaining American preeminence in biopharma discovery.
February 2, 2025 at 5:18 PM
I’m not naming a Best Biopharma CEO for 2024.

No individual CEO stood out from the pack this year. With that said, I did compile a deep list of biopharma CEOs whose accomplishments this year deserve recognition.

Read more about them:

www.statnews.com/2024/12/17/b...
Who stood out as Best Biopharma CEO of 2024?
Best Biopharma CEO of 2024, in @adamfeuerstein's view? No clear winner, but plenty of contenders.
www.statnews.com
December 17, 2024 at 12:44 PM
I can’t see how it wouldn’t hurt biopharma across the board.
November 14, 2024 at 9:25 PM
A demand that biopharma NOT cozy up to the Musk-Trump administration

"by the time you can unequivocally point to things that have started going wrong in industry because academic research has been stomped flat, it will be far too late to do anything about it"

www.science.org/content/blog...
Stand Up And Be Counted
www.science.org
February 24, 2025 at 2:52 PM